Markus L Lampert

发表

Inappropriate prescribing: a systematic overview of published assessment tools

Kurt E. Hersberger, Carole P Kaufmann, Regina M. Tremp, 2013, European Journal of Clinical Pharmacology.

Classification of drug-related problems with new prescriptions using a modified PCNE classification system

K. Hersberger, Markus L Lampert, P. Eichenberger, 2010, Pharmacy World & Science.

Documentation of pharmaceutical care: Validation of an intervention oriented classification system

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2017, Journal of evaluation in clinical practice.

M. Haschke, K. Hersberger, Markus L Lampert, 2011, International Journal of Clinical Pharmacy.

Outcomes of early switching from intravenous to oral antibiotics on medical wards

M. Battegay, B. Hug, U. Flückiger, 2009, The Journal of antimicrobial chemotherapy.

Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2018, Pharmacy.

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Samuel S. Allemann, Samuel S Allemann, H. E. Meyer zu Schwabedissen, 2022, Pharmacy.

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions

H. E. Meyer zu Schwabedissen, K. Hersberger, Markus L Lampert, 2021, Pharmacogenomics and personalized medicine.

PGPM_A_285807 279..286

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2021 .

Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2015, International Journal of Clinical Pharmacy.

Inappropriate prescribing: a systematic overview of published assessment tools

K. Hersberger, Markus L Lampert, Carole P. Kaufmann, 2013, European Journal of Clinical Pharmacology.

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene

Samuel S. Allemann, Samuel S Allemann, H. E. Meyer zu Schwabedissen, 2022, Frontiers in Psychiatry.

Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a case report.

H. E. Meyer zu Schwabedissen, T. Mikoteit, M. Hatzinger, 2020, Pharmacogenomics.

Drug use problems with self-injected low-molecular-weight heparins in primary care

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2011, European Journal of Clinical Pharmacology.

Detection and resolution of drug-related problems at hospital discharge focusing on information availability - a retrospective analysis.

P. Beeler, C. Rosen, K. Hersberger, 2021, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

Contribution of Patient Interviews as Part of a Comprehensive Approach to the Identification of Drug-Related Problems on Geriatric Wards

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2018, Drugs & Aging.

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process

K. Hersberger, Markus L Lampert, Carole P. Kaufmann, 2015, BMJ Open.

B. Hug, Markus L Lampert, Markus L. Lampert, 2008, Pharmacy World & Science.

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept

H. E. Meyer zu Schwabedissen, K. Hersberger, Markus L Lampert, 2021, Pharmacy.

Mapping clinical pharmacy practice in Swiss hospitals: a cross-sectional study

K. Hersberger, Markus L Lampert, M. Messerli, 2016, European journal of hospital pharmacy. Science and practice.

Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study

K. Hersberger, Markus L Lampert, R. Weidmann, 2018, BMJ Open.

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report

H. E. Meyer zu Schwabedissen, T. Mikoteit, M. Hatzinger, 2021, International journal of molecular sciences.

Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions

P. Bedouch, K. Hersberger, Markus L Lampert, 2018, International Journal of Clinical Pharmacy.

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study

Samuel S Allemann, H. E. Meyer zu Schwabedissen, K. Hersberger, 2023, Pharmacogenomics and personalized medicine.

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy

Samuel S. Allemann, Samuel S Allemann, H. E. Meyer zu Schwabedissen, 2023, Journal of personalized medicine.

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial

Samuel S. Allemann, Samuel S Allemann, H. E. Meyer zu Schwabedissen, 2021, Trials.

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report

H. E. Meyer zu Schwabedissen, T. Mikoteit, M. Hatzinger, 2021, Life.

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems

K. Hersberger, Markus L Lampert, Carole P. Kaufmann, 2018, BMJ Open.

Documentation of pharmaceutical care: development of an intervention oriented classification system

K. Hersberger, Markus L Lampert, Markus L. Lampert, 2017, International Journal of Clinical Pharmacy.